MIAMI, June 11, 2019 (GLOBE NEWSWIRE) — Healing Biosciences, Inc., (CBDX) (“Healing”) introduced in the present day the launch of its new line of Full-Spectrum CBD Oil Tinctures. The pharmaceutical grade hemp-derived CBD Oil Tinctures might be uniquely offered in a customized and molded black glass dropper bottle. Healing’s Full-Spectrum CBD Oil might be provided in 30ml bottles containing 250mg, 500mg, and 1,000mg CBD strengths in a Cool Mint taste.
- Zero THC
- Full-Spectrum Cannabinoids
- CO2 Extracted
- Lab-tested for High quality and Purity
- Non-GMO Hemp Crops
- Grown within the USA
- 100% Natural Farming; No Herbicides, Pesticides, or Chemical Fertilizers
- All Pure with no Components or Preservatives
“Our CBD oil merchandise are constituted of naturally developed genetic strains of Phytocannabinoid-Wealthy industrial hemp grown within the USA using natural farming practices. State-of-the-art cloning ensures consistency of the genetic strains and guarantees our health-conscious clients a secure and controlled product”, acknowledged Katherine West, Healing’s Chief Working Officer.
Hemp-derived CBD has been proven to be efficient in treating a variety of medical circumstances, together with sleep problems, anxiousness, sure varieties of epilepsy, arthritic and muscular ache, hypertension, and numerous pores and skin circumstances.
The introduction of this new of line CBD Oil Tinctures permits Healing Biosciences to satisfy the rising demand for CBD oil in the US, Canada and 60+ different nations. BDS Analytics and ArcView Market Analysis estimates the Cannabidiol (CBD) market will expertise 49% compounded annual development between 2018 to 2024 and develop to over $20 billion annual gross sales.
[email protected], http://www.curativebiosciences.com/, www.curativebio.com
About Healing Biosciences, Inc.
Healing Biosciences (CBDX), is creating a brand new class within the well being trade by translating advances in science and know-how into efficient, scientifically sound well being merchandise obtainable to folks of their on a regular basis lives. We’re creating a portfolio of merchandise with compelling compounds present in nature that provide a chance for our clients to proactively help their well being.
This press launch incorporates forward-looking statements as outlined inside Part 27A of the Securities Act of 1933, as amended, and Part 21E of the Securities Alternate Act of 1934, as amended. These statements relate to future occasions, together with our potential to boost capital, or to our future monetary efficiency, and contain recognized and unknown dangers, uncertainties and different elements that will trigger our precise outcomes, ranges of exercise, efficiency, or achievements to be materially completely different from any future outcomes, ranges of exercise, efficiency or achievements expressed or implied by these forward-looking statements. You shouldn’t place undue reliance on forward-looking statements since they contain recognized and unknown dangers, uncertainties and different elements that are, in some circumstances, past our management and which might, and sure will, materially have an effect on precise outcomes, ranges of exercise, efficiency or achievements. Any forward-looking assertion displays our present views with respect to future occasions and is topic to those and different dangers, uncertainties and assumptions referring to our operations, outcomes of operations, development technique and liquidity. We assume no obligation to publicly replace or revise these forward-looking statements for any cause, or to replace the explanations precise outcomes might differ materially from these anticipated in these forward-looking statements, even when new data turns into obtainable sooner or later. For a dialogue of those dangers and uncertainties, please see our filings with the Securities and Alternate Fee. Our public filings with the SEC can be found from business doc retrieval providers and on the web site maintained by the SEC at http://www.sec.gov.